The UK medical giant GlaxoSmithKline (LSE: GSK) has announced a new partnership with the Alphabet life science’s division Verily to create a UK based start-up called Galvani Bioelectronics. How will they work together?

Our top analysts have highlighted five shares in the FTSE 100 in our special free report "5 Shares To Retire On". To find out the names of the shares and the reasons behind their inclusion, simply click here to view it immediately with no obligations whatsoever.